Aurora Cannabis Inc revenue

Aurora Cannabis Inc's revenue was $232m in fiscal 2026, up 11.7% on the year before. Since fiscal 2019 ($43.5m) it has grown at a compound 27.0% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aurora Cannabis Inc: revenue history, annual
Fiscal year	2019Jun 2018	2020Jun 2019	2021Jun 2020	2022Jun 2021	2023Jun 2022	2024Mar 2024	2025Mar 2025	2026Mar 2026
Revenue	43	186	200	191	175	200	208	232
Growth on the year before	—	+326.8%	+7.9%	−4.4%	−8.7%	+14.4%	+3.9%	+11.7%
Gross profit	34	108	−15	−17	17	98	130	99
Gross margin	78.8%	58.0%	−7.4%	−8.8%	9.6%	48.9%	62.6%	42.6%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Aurora Cannabis Inc	$232m	11.7%	—
Vanda Pharmaceuticals Inc.	$229m	8.1%	2.7%
Harrow, Inc.	$276m	21.1%	39.0%
Organigram Global Inc.	$185m	57.8%	—
Biote Corp.	$184m	-7.8%	0.5%
Kamada LTD	$180m	12.1%	—

Compare with peers

Head to head: ACB vs VNDA ACB vs HROW ACB vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Aurora Cannabis Inc's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aurora Cannabis Inc.